SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
关外李少
Lv4
800 积分
2023-02-05 加入
最近求助
最近应助
互助留言
Pembrolizumab Plus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After 5 Years of Follow-Up
13天前
已完结
Targeting ATR in patients with cancer
13天前
已完结
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy
2个月前
已完结
Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer
2个月前
已完结
Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2)
2个月前
已完结
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
2个月前
已完结
Radionuclide-based theranostics — a promising strategy for lung cancer
2个月前
已完结
CDK4/6 inhibition sensitizes intracranial tumors to PD-1 blockade in preclinical models of brain metastasis
4个月前
已完结
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
4个月前
已完结
Validating chemoimmunotherapy in small-cell lung cancer
4个月前
已完结
没有进行任何应助
特别感谢少侠。
13天前
速度真快,感谢,点赞
2个月前
感谢,速度真快,点赞
2个月前
速度真快
4个月前
帮大忙了,么么哒
4个月前
速度真快,帮大忙了
6个月前
点赞,速度真快,帮大忙了
11个月前
速度真快
1年前
速度真快
1年前
点赞,速度真快,帮大忙了
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论